Not available
Quote | Aratana Therapeutics Inc. (NASDAQ:PETX)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $4.92 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 07/25/2019 04:53:24 pm |
News | Aratana Therapeutics Inc. (NASDAQ:PETX)
Elanco ( ELAN ) has seen an eventful year. Late September of 2018, the company was spun-off from Eli Lilly ( LLY ) into a pure play on animal health. When I reviewed the prospects for the company at the time, I concluded that the valuation of the entire sector (including Elanco) was too ...
Merger activity increased last week with four new deals announced and one pending deal closing. Deal Statistics: New Deals: The acquisition of Carrizo Oil & Gas ( CRZO ) by Callon Petroleum Company ( CPE ) for $3.2 billion in an all stock deal. Under the terms of the agreeme...
Message Board Posts | Aratana Therapeutics Inc. (NASDAQ:PETX)
Subject | By | Source | When |
---|---|---|---|
* * $PETX Video Chart 04-26-2019 * * | ClayTrader | investorshub | 04/26/2019 8:44:17 PM |
News: $PETX ALERT: Rowley Law PLLC is Investigating | whytestocks | investorshub | 04/26/2019 6:40:40 PM |
News: $PETX Elanco Announces Agreement to Acquire Aratana | whytestocks | investorshub | 04/26/2019 2:00:38 PM |
News: $PETX Aratana Therapeutics to be Acquired by | whytestocks | investorshub | 04/26/2019 1:50:41 PM |
I notified Admin so his passing can be | Wildbilly | investorshub | 03/19/2019 12:17:03 AM |
News, Short Squeeze, Breakout and More Instantly...
Aratana Therapeutics Inc. Company Name:
PETX Stock Symbol:
NASDAQ Market:
Aratana Therapeutics Inc. Website:
LEAWOOD, Kan. , July 16, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting results for the three proposals considered and vote...
TÜBINGEN, Germany and BOSTON, June 24, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced that Timothy Wright, M.D. and Craig Tooman were elected as independent directors to CureVac’s Supervisory ...
LEAWOOD, Kan. , June 11, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the U.S. Food and Drug Administration's Center for Veteri...